Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Ocugen, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
OCGN (Ocugen, Inc.) has 15 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move, and a bundle sits past the rings until you open it. Extended: satellites hang off single companies, not bundled sectors.
149 institutional managers report a position in Ocugen, Inc. worth $226.4M between them, filed on form 13F for the quarter ending 2026-06-30. 14 of them hold 80% of it, the largest being BlackRock, Inc. at 18.25%.
124 more managers in the register
14 managers hold 80% of the $226.4M institutional base. The other 135 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Ikarian Capital, LLC, RTW Investments, LLC, Marshall Wace LLP +3 more · 2.68% of OCGN, 3.60% of TENX
via RTW Investments, LLC, Marshall Wace LLP, Qube Research & Technologies Ltd +2 more · 4.51% of OCGN, 11.07% of CMPS
via RTW Investments, LLC, Marshall Wace LLP, Boothbay Fund Management, LLC +1 more · 4.51% of OCGN, 15.72% of MIST
via RTW Investments, LLC, Ikarian Capital, LLC, Marshall Wace LLP +1 more · 4.51% of OCGN, 7.21% of KLRS
via RTW Investments, LLC, Marshall Wace LLP, Qube Research & Technologies Ltd +1 more · 4.51% of OCGN, 17.68% of RCKT
via RTW Investments, LLC, Qube Research & Technologies Ltd, Marshall Wace LLP +1 more · 4.51% of OCGN, 4.22% of ACAD
Managers holding a meaningful stake in OCGN also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.